ISSN: 1078-0432

Clinical Cancer Research Q1 Unclaimed

American Association for Cancer Research Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

3500 €

Gold OA

-

Green OA

1500 €

Non OA

Metrics

5,241

SJR Impact factor

310

H Index

820

Total Docs (Last Year)

2202

Total Docs (3 years)

30206

Total Refs

20052

Total Cites (3 years)

2075

Citable Docs (3 years)

9,49

Cites/Doc (2 years)

36,84

Ref/Doc

Aims and Scope

Cancer Clinical Cancer Tumor Radiobiology Radiation Oncology

Other journals with similar parameters

Nature Reviews Clinical Oncology Q1
CA - A Cancer Journal for Clinicians Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of the National Cancer Institute Q1

Best articles

130-nm Albumin-Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain

A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy

A Randomized Phase II Study of Concurrent Docetaxel Plus Vaccine Versus Vaccine Alone in Metastatic Androgen-Independent Prostate Cancer

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway

Activation of Host Wound Responses in Breast Cancer Microenvironment

Anti-Folate Receptor alpha-directed Antibody Therapies Restrict the Growth of Triple Negative Breast Cancer

Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Anti-Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors

AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer

Circulating Matrix Metalloproteinase-9 Levels as a Biomarker of Disease

SHOW MORE ARTICLES

Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors

Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization

Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy

Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia

Combined Inhibition of Both p110a and p110beta Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer

Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans

Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells

Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/beta-Catenin Signaling

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer

Delta-Like Ligand 4 Plays a Critical Role in Pericyte/Vascular Smooth Muscle Cell Formation during Vasculogenesis and Tumor Vessel Expansion in Ewing's Sarcoma

Detection of Human Papillomavirus-16 in Fine-Needle Aspirates to Determine Tumor Origin in Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck

Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.